Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

NCT07152184 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

288

Enrollment

OTHER

Sponsor class

Conditions

Patient With Schizophrenia Spectrum Disorder
NLM Classification WM 203, Psychology:Schizophrenic Psychology
Schizophrenia Spectrum and Other Psychotic Disorders

Interventions

DRUG: Use of antipsychotic treatment with marketing authorization at doses lower than those recommended: - Olanzapine - Zuclopenthixol - Risperidone - Pipotiazine palmitate / Pipotiazine - Quetiapine - Flup

Sponsor

University Hospital, Strasbourg, France